Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Angew Chem Int Ed Engl. 2013 Jun 21;52(32):8295–8298. doi: 10.1002/anie.201303656

Figure 4.

Figure 4

Pharmacodynamics in mice. (A) Single doses of bGCSF (10 µg/kg) and Ab-bGCSF L0 and Ab-bGCSF L1 (50 µg/kg) were administrated by subcutaneous (s.c.) injection into BALB/c mice (3 per group). Blood was collected and analyzed for neutrophils by FACS using fluorophore-labeled anti-CD45, anti-CD11b, and anti-Ly-6G antibodies. (B) Representative flow cytometric analyses of mouse neutrophil populations after treatments with bGCSF, Ab-bGCSF L0 and Ab-bGCSF L1.